Halozyme Therapeutics (NASDAQ: HALO) announced its chief financial officer David Ramsay will retire this summer, and named biotech veteran Laurie ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE